Sarepta to pay Arrowhead $500M + in licensing deal for siRNA-based treatments
Sarepta Therapeutics (SRPT), the leader in precision genetic medicine for rare diseases announced an exclusive global licensing and collaboration agreement with Arrowhead (ARWR) Pharmaceuticals ( ARWR ...
Dow Jones Futures: Fed Inflation Data Due; Bitcoin Rises As CrowdStrike Leads Earnings Movers
Futures fell slightly with the Fed's favorite inflation gauge on tap. CrowdStrike leads key earnings movers. Amazon and ...
Arrowhead to get $825M in Sarepta licensing pact, appoints Sarepta CEO to board
Arrowhead (ARWR) announced a global licensing and collaboration agreement with Sarepta (SRPT). Upon closing, Arrowhead will receive $825M, consisting of $500M cash and $325M as an equity investment ...